Is Covid-19 seroprevalence different in health care workers as per their risk of exposure? A study from a tertiary care hospital in National Capital Region of India
Sushila Kataria(Medanta The Medicity), Naresh Trehan(Medanta The Medicity), Vikas Deswal(Medanta The Medicity), Rohit Dutt(Mahatma Gandhi Memorial Medical College), Kuldeep Kumar(GD Goenka University), Renu Saxena(Medanta The Medicity), Manish Kumar Singh(Indian Council of Forestry Research and Education), Pooja Sharma(Medanta The Medicity), Padam Singh(Medanta The Medicity), Smita Sarma(Medanta The Medicity), Sazid Alam(Medanta The Medicity), Vaibhav Gupta(Medanta The Medicity), Rashmi Phogat(Medanta The Medicity)
Cited by 6
Related Papers
Phytochemicals in Anticancer Drug Development
|Anti-Cancer Agents in Medicinal Chemistry|2018|82
Ageratum conyzoides L. and Its Secondary Metabolites in the Management of Different Fungal Pathogens
|Molecules|2021|75
Innovation in cancer therapeutics and regulatory perspectives
|Medical Oncology|2022|71
Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded β-Cyclodextrin Nanosponges
|Journal of Pharmaceutical Sciences|2021|70
RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy
|International Journal of Pharmaceutics|2023|67